Mesenteric Venous Thrombosis Treatment Outcomes and Prognosis: Scoping Review with ☸️SAIMSARA

To synthesize current evidence regarding mesenteric venous thrombosis. The review uses 436 references and builds its evidence map from 1058 original studies with 159421 total participants/sample observations (topic-deduplicated ΣN). This scoping review suggests that mesenteric venous thrombosis is best approached as a high-risk yet increasingly treatable splanchnic thrombosis in which early cross-sectional imaging and prompt anticoagulation form the management core, with escalation reserved for threatened bowel. Anticoagulation, including both vitamin K antagonists and direct oral agents, was associated with favorable recanalization and low recurrence, and a medical-first policy was associated with reduced mortality from 39% to 11%. Outcomes appear more favorable than arterial mesenteric ischemia, though early mortality and progression to portal hypertensive sequelae remain clinically important. Because the evidence is dominated by case series and uncontrolled cohorts without randomized comparisons, these signals should be interpreted as descriptive patterns rather than confirmed effects. Future prospective comparative trials using standardized recanalization, bowel-preservation, and bleeding endpoints are needed to clarify optimal anticoagulant choice, duration, and the role of endovascular escalation.

Authors

Publication Details

Journal
SAIMSARA Journal
Published
2026-11-13
DOI
https://doi.org/10.62487/saimsarae883c7a8
Primary Topic
Abdominal vascular conditions and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mesenteric Venous Thrombosis Treatment Outcomes and Prognosis: Scoping Review with ☸️SAIMSARA

SAIMSARA
1 links
SAIMSARA Journal
Abdominal vascular conditions and treatments
article

Mesenteric Venous Thrombosis Treatment Outcomes and Prognosis: Scoping Review with ☸️SAIMSARA

SAIMSARA
article en

Abstract

To synthesize current evidence regarding mesenteric venous thrombosis. The review uses 436 references and builds its evidence map from 1058 original studies with 159421 total participants/sample observations (topic-deduplicated ΣN). This scoping review suggests that mesenteric venous thrombosis is best approached as a high-risk yet increasingly treatable splanchnic thrombosis in which early cross-sectional imaging and prompt anticoagulation form the management core, with escalation reserved for threatened bowel. Anticoagulation, including both vitamin K antagonists and direct oral agents, was associated with favorable recanalization and low recurrence, and a medical-first policy was associated with reduced mortality from 39% to 11%. Outcomes appear more favorable than arterial mesenteric ischemia, though early mortality and progression to portal hypertensive sequelae remain clinically important. Because the evidence is dominated by case series and uncontrolled cohorts without randomized comparisons, these signals should be interpreted as descriptive patterns rather than confirmed effects. Future prospective comparative trials using standardized recanalization, bowel-preservation, and bleeding endpoints are needed to clarify optimal anticoagulant choice, duration, and the role of endovascular escalation.

SAIMSARA JournalVol. 1(1)
Good health and well-being
Abdominal vascular conditions and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon